NCT03464461

Dosing of Ketorolac in the Emergency Department

Dosing of Ketorolac for Four Classes of Complaints in the Emergency Department

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 289 (actual)
• Sponsor: University of Missouri-Columbia · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The optimal dose of ketorolac in the Emergency Department setting is no clear. We will compare 3 doses to determine the optimal dose.

Detailed description

Patients from 4 groups will be treated with 3 different doses of ketorolac. The groups are 1. headache 2. abdominal pain 3. musculo-skeletal pain 4. viral syndrome. The doses will be 0, 10, 30mgs of ketorolac to clarify the placebo effect and the optimal dosage as a function of condition.

Conditions

• Acute Pain

Interventions

Type	Name	Description
DRUG	Ketorolac	IV drug

Timeline

• Start date: 2018-05-01
• Primary completion: 2024-05-30
• Completion: 2024-05-30
• First posted: 2018-03-14
• Last updated: 2024-11-05
• Results posted: 2024-11-05

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study